VRTX vs CRSP
VRTX 与 CRSP 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | VRTXVERTEX PHARMACEUTICALS INC / MA | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| 市值 | $141.70B | $4.97B |
| 市盈率(TTM) | 32.6 | — |
| 市净率 | 7.00 | — |
| 市销率 | 11.8x | 1415.8x |
| 营收 | $12.59B(TTM) | — |
| 营收同比增长 | 8.9% | -90.6% |
| 净利润 | $4.41B(TTM) | — |
| 净利同比增长 | 838.1% | -58.8% |
| 每股收益(稀释) | $17.17(TTM) | — |
| 息税前利润率 | 34.8% | -18933.6% |
| 净资产收益率 | 19.5% | -33.3% |
| 投入资本回报率 | 25.0% | -32.6% |
| 一年总回报 | +33.1% | -15.9% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:VRTX vs CRSP
| 指标 | VRTX | CRSP |
|---|---|---|
| 期末价值 | $68.3K | $36.5K |
| 总回报 | +583.0% | +264.9% |
| 年化收益 (CAGR) | +21.1% | +13.8% |
| 波动率 | 32.6% | 63.9% |
| 夏普比率 | 0.62 | 0.45 |
| 索提诺比率 | 0.92 | 0.70 |
| 最大回撤 | -41.6% | -85.1% |
基于 2522 个共同交易日,2016-10-19 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)